<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5AB6AF3-9BC1-4877-9784-74C8145C7032"><gtr:id>F5AB6AF3-9BC1-4877-9784-74C8145C7032</gtr:id><gtr:name>The Wenner-Gren Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/358AC957-81B4-4AD3-8AEF-0D0CB8CA7024"><gtr:id>358AC957-81B4-4AD3-8AEF-0D0CB8CA7024</gtr:id><gtr:name>Zora Biosciences Oy</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1E06C677-C6F2-4B03-A434-0CB4CAD49D81"><gtr:id>1E06C677-C6F2-4B03-A434-0CB4CAD49D81</gtr:id><gtr:name>Technical Research Centre of Finland (VTT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514"><gtr:id>926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514</gtr:id><gtr:name>German Cancer Research Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Clinical Biochemist</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5AB6AF3-9BC1-4877-9784-74C8145C7032"><gtr:id>F5AB6AF3-9BC1-4877-9784-74C8145C7032</gtr:id><gtr:name>The Wenner-Gren Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/358AC957-81B4-4AD3-8AEF-0D0CB8CA7024"><gtr:id>358AC957-81B4-4AD3-8AEF-0D0CB8CA7024</gtr:id><gtr:name>Zora Biosciences Oy</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1E06C677-C6F2-4B03-A434-0CB4CAD49D81"><gtr:id>1E06C677-C6F2-4B03-A434-0CB4CAD49D81</gtr:id><gtr:name>Technical Research Centre of Finland (VTT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514"><gtr:id>926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514</gtr:id><gtr:name>German Cancer Research Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/521E032C-C065-41B2-9CEA-9A06C8BC5312"><gtr:id>521E032C-C065-41B2-9CEA-9A06C8BC5312</gtr:id><gtr:firstName>Antonio</gtr:firstName><gtr:surname>Vidal-Puig</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400192"><gtr:id>0F931138-3538-4C0D-9C97-6B97545D303C</gtr:id><gtr:title>Lipotoxicity, a common patogenic mechanism of the Metabolic Syndrome</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400192</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>385299</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Nutrition Research Unit</gtr:department><gtr:description>Lipidomic technology</gtr:description><gtr:id>54689905-CC44-420E-81B0-19677582E74D</gtr:id><gtr:impact>1.Medina-Gomez G, Yetukuri L, Velagapudi V, Campbell M, Blount M, Jimenez-Linan M, Ros M, Oresic M, Vidal-Puig A. Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech. 2009 Nov-Dec;2(11-12):582-92. Epub 2009 Oct 19. PMID: 19841237 2.Tang J, Tan CY, Oresic M, Vidal-Puig A.Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.Genome Med. 2009 Mar 30;1(3):35.PMID: 19341506 3.Oresic M, H&amp;auml;nninen VA, Vidal-Puig A.Lipidomics: a new window to biomedical frontiers. Trends Biotechnol. 2008 Dec;26(12):647-52. Epub 2008 Oct 23. PMID: 18951641 4.Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M.Informatics and computational strategies for the study of lipids. Mol Biosyst. 2008 Feb;4(2):121-7. PMID: 18213405 5.Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Sepp&amp;auml;nen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.PLoS Genet. 2007 Apr 27;3(4):e64. PMID: 17465682 6.Yetukuri L, Katajamaa M, Medina-Gomez G, Sepp&amp;auml;nen-Laakso T, Vidal-Puig A, Oresic M.Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.BMC Syst Biol. 2007 Feb 15;1:12. PMID: 17408502 7.Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N, Curtis K, Campbell M, Hu P, Zhang D, Litwin SE, Zaha VG, Fountain KT, Boudina S, Jimenez-Linan M, Blount M, Lopez M, Meirhaeghe A, Bohlooly-Y M, Storlien L, Str&amp;ouml;mstedt M, Snaith M, Oresic M, Abel ED, Cannon B, Vidal-Puig A.Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance.PLoS Biol. 2006 Nov;4(11):e369.PMID: 17090215 8.Oresic M, Vidal-Puig A, H&amp;auml;nninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases.Expert Rev Mol Diagn. 2006 Jul;6(4):575-85. Review. PMID: 16824031 

15. Virtue S, F.H., Christian M, Tan CY, Masoodi M, Dale M, et al (10 authors) Vidal-Puig A. Diabetes in press (2012), A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes, (2012.)

Virtue, S., M. Christian, C. Tan, M. Masoodi, M. Dale, C. ( 10 authors) A. Vidal-Puig, A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 2012.

Griffin, J.L. and A. Vidal-Puig, Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics, 2008. 34(1): p. 1-5.

Pietilainen, K.H., T. Rog, T. Seppanen-Laakso, S. Virtue, P. Gopalacharyulu, J.(16 authors), A. Vidal-Puig, and M. Oresic, Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol, 2011. 9(6): p. e1000623.
19. Prieur, X., C.Y. Mok, V.R. Velagapudi, V. Nunez, L. Fuentes, D. (9 authors), A. Vidal-Puig, Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes, 2011. 60(3): p. 797-809.
20. Kilpelainen, T.O., M.C. Zillikens, A. Stancakova, F.M. Finucane, J.S. Ried, C. Langenberg, (65 authors) A. Vidal-Puig, (40 authors) R.J. Loos, Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet, 2011. 43(8): p. 753-60.
21. Medina-Gomez, G., L. Yetukuri, V. Velagapudi, M. Campbell, M. Blount,et al (3 authors), A. Vidal-Puig, Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech, 2009. 2(11-12): p. 582-92.
22. Vivas, Y., C. Martinez-Garcia, A. Izquierdo, F. Garcia-Garcia, S. Callejas, (4 authors), A. Vidal-Puig, and G. Medina-Gomez, Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics, 2012. 4: p. 86.
Virtue S, Feldmann H, Christian M, Tan CY, Masoodi M, Dale M, Lelliott C, Burling K, Campbell M, Eguchi N, Voshol P, Sethi JK, Parker M, Urade Y, Griffin JL, Cannon B, Vidal-Puig A. A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 61(12):3139-47 (2012).

4. Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY, Sicard A, Atherton HJ, Barbarroja N, Bjursell M, Bohlooly-Y M, Virtue S, Tuthill A, Lefai E, Laville M, Wu T, Considine RV, Vidal H, Langin D, Oresic M, Tinahones FJ, Fernandez-Real JM, Griffin JL, Sethi JK, L&amp;oacute;pez M, Vidal-Puig A. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes 2013 Aug 6. [Epub ahead of print]

12. Virtue S, Masoodi M, Velagapudi V, Tan CY, Dale M, Suorti T, Slawik M, Blount M, Burling K, Campbell M, Eguchi N, Medina-Gomez G, Sethi JK, Ore?ic M, Urade Y, Griffin JL, Vidal-Puig A. Lipocalin Prostaglandin D Synthase and PPAR?2 Coordinate to Regulate Carbohydrate and Lipid Metabolism In Vivo. PLoS One 7(7):e39512. (2012)

Rodriguez-Cuenca S, Carobbio S, Velagapudi VR, Barbarroja N, Moreno-Navarrete JM, Tinahones FJ, Fernandez-Real JM, Oresic M, Vidal-Puig A. PPAR? DEPENDENT REGULATION OF LIPOLYTIC NODES AND METABOLIC FLEXIBILITY. Moll Cell Biol. 2012 Feb 6.</gtr:impact><gtr:outcomeId>CDC21732DE6-2</gtr:outcomeId><gtr:partnerContribution>Providing lipidomic analysis from biological samples.</gtr:partnerContribution><gtr:piContribution>provided intellectual framework, experimental design and biological samples.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical Research Centre of Finland (VTT)</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:department>Matej Oresic VTT</gtr:department><gtr:description>Lipidomic technology</gtr:description><gtr:id>AA14B7F4-ED24-44F0-8FE9-2AC5A76ED139</gtr:id><gtr:impact>1.Medina-Gomez G, Yetukuri L, Velagapudi V, Campbell M, Blount M, Jimenez-Linan M, Ros M, Oresic M, Vidal-Puig A. Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech. 2009 Nov-Dec;2(11-12):582-92. Epub 2009 Oct 19. PMID: 19841237 2.Tang J, Tan CY, Oresic M, Vidal-Puig A.Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.Genome Med. 2009 Mar 30;1(3):35.PMID: 19341506 3.Oresic M, H&amp;auml;nninen VA, Vidal-Puig A.Lipidomics: a new window to biomedical frontiers. Trends Biotechnol. 2008 Dec;26(12):647-52. Epub 2008 Oct 23. PMID: 18951641 4.Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M.Informatics and computational strategies for the study of lipids. Mol Biosyst. 2008 Feb;4(2):121-7. PMID: 18213405 5.Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Sepp&amp;auml;nen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.PLoS Genet. 2007 Apr 27;3(4):e64. PMID: 17465682 6.Yetukuri L, Katajamaa M, Medina-Gomez G, Sepp&amp;auml;nen-Laakso T, Vidal-Puig A, Oresic M.Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.BMC Syst Biol. 2007 Feb 15;1:12. PMID: 17408502 7.Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N, Curtis K, Campbell M, Hu P, Zhang D, Litwin SE, Zaha VG, Fountain KT, Boudina S, Jimenez-Linan M, Blount M, Lopez M, Meirhaeghe A, Bohlooly-Y M, Storlien L, Str&amp;ouml;mstedt M, Snaith M, Oresic M, Abel ED, Cannon B, Vidal-Puig A.Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance.PLoS Biol. 2006 Nov;4(11):e369.PMID: 17090215 8.Oresic M, Vidal-Puig A, H&amp;auml;nninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases.Expert Rev Mol Diagn. 2006 Jul;6(4):575-85. Review. PMID: 16824031 

15. Virtue S, F.H., Christian M, Tan CY, Masoodi M, Dale M, et al (10 authors) Vidal-Puig A. Diabetes in press (2012), A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes, (2012.)

Virtue, S., M. Christian, C. Tan, M. Masoodi, M. Dale, C. ( 10 authors) A. Vidal-Puig, A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 2012.

Griffin, J.L. and A. Vidal-Puig, Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics, 2008. 34(1): p. 1-5.

Pietilainen, K.H., T. Rog, T. Seppanen-Laakso, S. Virtue, P. Gopalacharyulu, J.(16 authors), A. Vidal-Puig, and M. Oresic, Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol, 2011. 9(6): p. e1000623.
19. Prieur, X., C.Y. Mok, V.R. Velagapudi, V. Nunez, L. Fuentes, D. (9 authors), A. Vidal-Puig, Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes, 2011. 60(3): p. 797-809.
20. Kilpelainen, T.O., M.C. Zillikens, A. Stancakova, F.M. Finucane, J.S. Ried, C. Langenberg, (65 authors) A. Vidal-Puig, (40 authors) R.J. Loos, Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet, 2011. 43(8): p. 753-60.
21. Medina-Gomez, G., L. Yetukuri, V. Velagapudi, M. Campbell, M. Blount,et al (3 authors), A. Vidal-Puig, Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech, 2009. 2(11-12): p. 582-92.
22. Vivas, Y., C. Martinez-Garcia, A. Izquierdo, F. Garcia-Garcia, S. Callejas, (4 authors), A. Vidal-Puig, and G. Medina-Gomez, Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics, 2012. 4: p. 86.
Virtue S, Feldmann H, Christian M, Tan CY, Masoodi M, Dale M, Lelliott C, Burling K, Campbell M, Eguchi N, Voshol P, Sethi JK, Parker M, Urade Y, Griffin JL, Cannon B, Vidal-Puig A. A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 61(12):3139-47 (2012).

4. Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY, Sicard A, Atherton HJ, Barbarroja N, Bjursell M, Bohlooly-Y M, Virtue S, Tuthill A, Lefai E, Laville M, Wu T, Considine RV, Vidal H, Langin D, Oresic M, Tinahones FJ, Fernandez-Real JM, Griffin JL, Sethi JK, L&amp;oacute;pez M, Vidal-Puig A. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes 2013 Aug 6. [Epub ahead of print]

12. Virtue S, Masoodi M, Velagapudi V, Tan CY, Dale M, Suorti T, Slawik M, Blount M, Burling K, Campbell M, Eguchi N, Medina-Gomez G, Sethi JK, Ore?ic M, Urade Y, Griffin JL, Vidal-Puig A. Lipocalin Prostaglandin D Synthase and PPAR?2 Coordinate to Regulate Carbohydrate and Lipid Metabolism In Vivo. PLoS One 7(7):e39512. (2012)

Rodriguez-Cuenca S, Carobbio S, Velagapudi VR, Barbarroja N, Moreno-Navarrete JM, Tinahones FJ, Fernandez-Real JM, Oresic M, Vidal-Puig A. PPAR? DEPENDENT REGULATION OF LIPOLYTIC NODES AND METABOLIC FLEXIBILITY. Moll Cell Biol. 2012 Feb 6.</gtr:impact><gtr:outcomeId>CDC21732DE6-1</gtr:outcomeId><gtr:partnerContribution>Providing lipidomic analysis from biological samples.</gtr:partnerContribution><gtr:piContribution>provided intellectual framework, experimental design and biological samples.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Osaka University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>LPGD2S KO MOUSe</gtr:description><gtr:id>49CAC62F-FCC9-48C0-9EEE-F6213FE009DA</gtr:id><gtr:impact>Papers still under submission expected to be published during 2010</gtr:impact><gtr:outcomeId>1B72A8A6CCB-1</gtr:outcomeId><gtr:partnerContribution>provided animal models for MRC funded project.</gtr:partnerContribution><gtr:piContribution>Phenotyping of mouse models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Molecular mechanisms of mitochondrial biogenesis</gtr:description><gtr:id>62057D61-9565-4BDE-9151-C4C81B5ADFEC</gtr:id><gtr:impact>Integration in FP7 Etherpath grant</gtr:impact><gtr:outcomeId>9D872B81BCD-2</gtr:outcomeId><gtr:partnerContribution>Providing animal models generated by AZaccess to lipidomic platforms</gtr:partnerContribution><gtr:piContribution>Provided biological samples for platform development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Zora Biosciences Oy</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>Molecular mechanisms of mitochondrial biogenesis</gtr:description><gtr:id>4968C2E9-D266-4FA2-AF93-E162893B3887</gtr:id><gtr:impact>Integration in FP7 Etherpath grant</gtr:impact><gtr:outcomeId>9D872B81BCD-3</gtr:outcomeId><gtr:partnerContribution>Providing animal models generated by AZaccess to lipidomic platforms</gtr:partnerContribution><gtr:piContribution>Provided biological samples for platform development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>German Cancer Research Center</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Flies as a disease model to study metabolic disease</gtr:description><gtr:id>A0A5FB70-9127-47A4-AE50-6B434A0753AE</gtr:id><gtr:impact>Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>58b97d594c8467.91167921-1</gtr:outcomeId><gtr:partnerContribution>generation of genetically modified flies mimicking mouse or cell genetic modification.</gtr:partnerContribution><gtr:piContribution>provide hypothesis for validation in flies and also perform experiments in mammalian systems with insights coming from flies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Molecular mechanisms of mitochondrial biogenesis</gtr:description><gtr:id>A87D733C-4F54-474B-A97D-A7C84A14F3DA</gtr:id><gtr:impact>Integration in FP7 Etherpath grant</gtr:impact><gtr:outcomeId>9D872B81BCD-1</gtr:outcomeId><gtr:partnerContribution>Providing animal models generated by AZaccess to lipidomic platforms</gtr:partnerContribution><gtr:piContribution>Provided biological samples for platform development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wenner-Gren Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Phsyiology</gtr:department><gtr:description>Brown fat</gtr:description><gtr:id>A35F604F-7582-4687-94AD-7A34BF8AC688</gtr:id><gtr:impact>Virtue S, Feldmann H, Christian M, Tan CY, Masoodi M, Dale M, Lelliott C, Burling K, Campbell M, Eguchi N, Voshol P, Sethi JK, Parker M, Urade Y, Griffin JL, Cannon B, Vidal-Puig A. A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 61(12):3139-47 (2012).Virtue S, F.H., Christian M, Tan CY, Masoodi M, Dale M, et al (10 authors) Vidal-Puig A. Diabetes in press (2012), 
Virtue, S., M. Christian, C. Tan, M. Masoodi, M. Dale, ( 10 authors) A. Vidal-Puig, A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes (in press) 2012.

Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.</gtr:impact><gtr:outcomeId>rGM9RiYT3WW-1</gtr:outcomeId><gtr:partnerContribution>Knowledge and technology</gtr:partnerContribution><gtr:piContribution>We have developed a new area of research focused on BAT</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>University of Santiago (Spain)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1E982EC4-678E-491C-A7DD-5BEEFC14E596</gtr:id><gtr:impact>Teaching science to undergraduates

Extend the impact of UK research abroad.</gtr:impact><gtr:outcomeId>1F3BF6B0F11</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Prof Vidal-Puig. radio Interview EITB Basque Country</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>91DF33CE-D187-4435-935F-017B5CF5C13B</gtr:id><gtr:impact>http://www.eitb.com/es/audios/detalle/841034/audio-obesos-saludables-anillamiento-aves-nuevas-tecnologias/

Prof. Vidal-Puig discussed for the EITB radio (Basque country, Spain) the impact of the environmental factors contributing to the obesity pandemic in the last half century; the concepts of adipose tissue expandability and the paradox of the &amp;quot;healthy obese&amp;quot; as well as the possibility of developing new strategies aimed to increase energy expenditure to fight against obesity and associated metabolic diseases.</gtr:impact><gtr:outcomeId>b6cY7BEw7mr</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A2FE59A4-A0FC-459D-9049-84254AD89FBD</gtr:id><gtr:impact>Edmonton, Canada. 2nd May 2016. Distinguished Speaker Lecture, University of Alberta. !50 approx. students and post docts attended lecture.</gtr:impact><gtr:outcomeId>58b98053e88623.44309685</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ADA 2016.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BED00F44-9EB6-454D-BA03-86DE6FE2A12E</gtr:id><gtr:impact>New Orleans, USA. 10th - 14th June 2016. American Diabetes Association's Scientific Session's 76th Scientific Sessions.</gtr:impact><gtr:outcomeId>58b98180728ea5.03435349</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>wide audience publishing</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DFC68C62-8308-4ECC-836E-D90153BDAF2F</gtr:id><gtr:impact>Publication in Journals without impact factor for general publisc with interest in science.

Communicating science to young individuals</gtr:impact><gtr:outcomeId>41A666BF8CE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Malaga, Spain. 19th - 21st October 2016. Congress of the Spanish Society of Endocrinology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A8A717D9-D3CA-480A-AE43-66387176826E</gtr:id><gtr:impact>Malaga, Spain. 19th - 21st October 2016. Congress of the Spanish Society of Endocrinology</gtr:impact><gtr:outcomeId>58b98398b08817.10851895</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3. Tsukuba, Japan. 17th-19th September 2016. Tsukuba Global Science Week.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CBF2DDB0-5B22-41C8-B44E-B52860394FA4</gtr:id><gtr:impact>Tsukuba, Japan. 17th-19th September 2016. Tsukuba Global Science Week.</gtr:impact><gtr:outcomeId>58b981f751d4a8.64003747</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C19702AF-9B43-4345-B3AC-A70DA9A34ECF</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>5455116d840832.39891014</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Keystone Symposia on Diabetes/Obesity and Adipose Tissue Biology.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>055DE9BC-85BF-4246-81FB-E187C2FF2B7F</gtr:id><gtr:impact>. Colorado, USA. 22nd - 27th January 2017. Keystone Symposia on Diabetes/Obesity and Adipose Tissue Biology.</gtr:impact><gtr:outcomeId>58b982c2d25053.22864172</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>99956975-2184-4F3D-936E-AFC9E43CADDB</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>54551178adc754.68257565</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Members of the TVP lab recently attended the 1st ICAN conference series in Cardiometabolic Disease in Paris.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>407A3A36-DC84-4898-BF56-F57D3B150419</gtr:id><gtr:impact>TVP Lab members give presentations and posters at 1st ICAN conference series in Cardiometabolic Disease

Members of the TVP lab recently attended the 1st ICAN conference series in Cardiometabolic Disease in Paris. Vanessa Pellegrinelli was selected to give a presentation, and Camilla Ingvorsen, Guillaume Bidault, and Vivian Peirce were selected to present posters. Vivian Peirce was a joint-winner of Young Investigator poster award.



Projection of our lab</gtr:impact><gtr:outcomeId>5455123f7d4751.15222608</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Vienna, Austria. 15th-19th October 2016.  UEG Week.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>01D43637-368F-49C2-8017-6CAA3E1696E0</gtr:id><gtr:impact>2. Vienna, Austria. 15th-19th October 2016. UEG Week. Main meeting on gastroenterology in Europe.</gtr:impact><gtr:outcomeId>58b98259303547.44144760</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>. London, UK. 11th January 2017. Seminar at the MRC Clinical Sciences Centre, Imperial College London.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D804490E-51C2-4CD0-8F8F-21DB20C5A0E8</gtr:id><gtr:impact>. London, UK. 11th January 2017. Seminar at the MRC Clinical Sciences Centre, Imperial College London.</gtr:impact><gtr:outcomeId>58b98434549387.91569087</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog BAT</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3392F1DC-BA4E-4079-9BBA-D610B6096307</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>5455117e311dc1.11948341</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Southern Furen, Denmark</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E2E01EF7-793D-49CF-A2EB-CAE3A8D6B770</gtr:id><gtr:impact>Teaching to PhD students from Denmark

Disseminating Science and attracting some of these excellent student to post doctoral training in UK.</gtr:impact><gtr:outcomeId>BF529CA4F9D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>. Cambridge, UK. 11th April 2016. British Heart Foundation Cardiovascular Research Excellence Annual Event.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5BAF2312-40A3-4073-990F-B617F3B5E7EE</gtr:id><gtr:impact>4. Cambridge, UK. 11th April 2016. British Heart Foundation Cardiovascular Research Excellence Annual Event.</gtr:impact><gtr:outcomeId>58b98346c7da56.88258600</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Heidelberg, Germany. 12th May 2016. Seminar at German Cancer Research Center (DKFZ)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5C85EB80-D259-4AE0-9BE4-69769AA9C5D0</gtr:id><gtr:impact>Heidelberg, Germany. 12th May 2016. Seminar at German Cancer Research Center (DKFZ)</gtr:impact><gtr:outcomeId>58b981305fb9c4.50658075</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>145520</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>178712AA-8996-4AFD-8386-3C4E2EB8B0BA</gtr:id><gtr:outcomeId>D157BB36EEC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5D64E043-457B-4189-B001-DF1865DB941D</gtr:id><gtr:outcomeId>AE8D98C00FD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>665546</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Translational Research Grant (Metabolic and cardiovascular Disease)</gtr:description><gtr:end>2010-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>73FB6685-0A3F-486C-A6BC-3D256F46FEFB</gtr:id><gtr:outcomeId>B5444E601100</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HEPADIP (11.7m euros across 24 participants)</gtr:description><gtr:end>2010-02-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>2860597F-D3CF-4F56-A4F7-AE35CB553F50</gtr:id><gtr:outcomeId>EFBA96A35C00</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2005-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>379685</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant (The role of wnt signalling network in adipose tissue development and plasticity)</gtr:description><gtr:end>2009-02-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>FBAEE6CE-DD9A-40EF-B642-F9905DBC1196</gtr:id><gtr:outcomeId>1EB179352200</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Organisation of conferences/Courses</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>1472BEB3-AA2D-405D-A71A-DE5220A3A3E7</gtr:id><gtr:impact>It is expected these training schemes have contributed to better care and scientifc developments.

Member of the Scientific Organising Committee

1. Cambridge, United Kingdom. 30th June - 2nd July 2015. EAS Advanced Course in Cardiometabolic Phenotyping in Rodents.
2. Boston, USA. 5th - 9th June 2015. ADA Scientific Sessions Insulin Action/Molecular Metabolism.
3. Colorado, USA. 9th - 13th February 2015. Keystone Symposia - Systems Biology of Lipid Metabolism. 
4. Madrid, Spain. 7th - 8th November 2014. CNIC Conference &amp;quot;Energy homeostasis and metabolic disease&amp;quot;. 
5. Madrid, Spain. 7th-8th November 2014. Energy homeostasis and metabolic disease. CNIC.
6. Cambridge, UK. 30th September 2014. 14th Annual Cambridge Immunology Forum Meeting. 


? Member of the Scientific Organising Committee Keystone meeting on Nuclear receptors. (http://www.keystonesymposia.org/Meetings/viewMeetings.cfm?MeetingID=1235?Tab=travel) Austria (2013)
? Member of the Scientific Organising Committee 15th European Congress of Endocrinology 27th April - 1st May 2013. Copenhagen, Denmark (http://www.ece2013.org/committees.aspx)
? Director of The European Atherosclerosis Society Advanced Course IV: Murine Genetics and Cardiometabolic Phenotyping 11th - 14th July 2012. Cambridge, United Kingdom (http://www.eas-society.org/advanced-course-iv,-cambridge.aspx
? Member of the Organising Scientific Committee of The Royal Society and Academy of Medical Sciences symposium on &amp;quot;Brown adipose tissue: a new human organ?&amp;quot; London (2012) (http://www.physoc.org/me2012) 
? Member of the Organising Scientific Committee The Obese Species Workshop Sicily, Italy. 21st - 26th October (2011) http://theobesespecies.unipr.it/.
? Member of the Organising Scientific Committee for the meeting of the EAS in Hamburg. Germany (2010)
? Member of the Organising Scientific Committee of the 49th International Conference on the Bioscience of Lipids. Maastrich (2008)</gtr:impact><gtr:outcomeId>scYTFVx5j3f</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Improved equipment for simultaneous measurement of food intake, energy expnditure, activity, drinking behaviour.</gtr:description><gtr:id>F67A42D0-069C-439F-84A4-35D7784CBE06</gtr:id><gtr:impact>In the process of trying to get patent.</gtr:impact><gtr:outcomeId>F34B14777A6</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Development of New equipment for mouse phenotyping.</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Microarray and lipidomic data form in vivo experiments using animal models</gtr:description><gtr:id>000B657D-52DD-4B80-A580-E53CDA3807E5</gtr:id><gtr:impact>This material has been utilised by other EU groups focused in modelling and development of tools for nutritional research</gtr:impact><gtr:outcomeId>8668068A9B9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Microarray/lipidomic  data bases</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of three core facilities, a) Murine phenotyping, b) Murine Biochemistry and c) Murine Histopathology</gtr:description><gtr:id>52B78DDE-1EE2-49E9-9D6E-646E1C0DD82B</gtr:id><gtr:impact>Development of MRC CORD murine metabolic programme
Development and expansion vreating the Cambridge Phenomics centre.</gtr:impact><gtr:outcomeId>D218E862BCE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of the Phenomics center</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have contributed to develop methods for lipid analysis</gtr:description><gtr:id>42D2BBF2-EF85-4A24-9874-D8AB5B204492</gtr:id><gtr:impact>1) Oresic M, H?nninen VA, Vidal-Puig A.Lipidomics: a new window to biomedical frontiers.Trends Biotechnol. 2008 Dec;26(12):647-52. Epub 2008 Oct 23PMID: 18951641 2)Tang J, Tan CY, Oresic M, Vidal-Puig A. Integrating post-genomic approaches as a strategy to advance our understanding of health and disease. Genome Med. 2009 Mar 30;1(3):35. [Epub ahead of print] PMID: 19341506 3) Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M. Informatics and computational strategies for the study of lipids.Mol Biosyst. 2008 Feb;4(2):121-7. Epub 2007 Dec 18. Review. 4).Oresic M, Vidal-Puig A, H?nninen V.Metabolomic approaches to phenotype characterization and applications to complex diseases.Expert Rev Mol Diagn. 2006 Jul;6(4):575-85. Review.</gtr:impact><gtr:outcomeId>4BBCE927162</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of methodology for microarray and lipidomic analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18951641</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Protocols do differentiation of Human PSC to brown, white and macrophage phenotype</gtr:description><gtr:id>D0492A34-3ACF-47B9-81E5-FC6EF034BF7E</gtr:id><gtr:impact>Competitiveness in our research and funding acquisition e.g. ERC grant</gtr:impact><gtr:outcomeId>58b98562619a65.89624617</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Differentiation of ES cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>LEM-PCR: a method for determining relative transcript isoform proportions using real-time PCR without a standard curve.Virtue S, Dale M, Sethi JK, Vidal-Puig A.
Genome. 2010 Aug;53(8):637-42.</gtr:description><gtr:id>37EC8D98-A386-4D10-9800-6795BC8D47AE</gtr:id><gtr:impact>Improved accuracy of data analysis</gtr:impact><gtr:outcomeId>qQxNc6Q64uw</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Tools for data quatification</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6ED2EE06-18E2-49B3-B951-DED88BA5D726</gtr:id><gtr:title>Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8face52ad7d0211d931dd00159b1afe3"><gtr:id>8face52ad7d0211d931dd00159b1afe3</gtr:id><gtr:otherNames>Hall Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>58b96da93d0964.82121958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8B1F3B4-0BAB-4173-8DE9-890EE10E5F51</gtr:id><gtr:title>Metabolic gene expression profile in circulating mononuclear cells reflects obesity-associated metabolic inflexibility.</gtr:title><gtr:parentPublicationTitle>Nutrition &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1c9e5d1b95764179492b943002f2d9"><gtr:id>dd1c9e5d1b95764179492b943002f2d9</gtr:id><gtr:otherNames>Baig S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1743-7075</gtr:issn><gtr:outcomeId>58b96da960e967.60769792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>780CA2C6-6F51-4A14-9DBE-B68594380277</gtr:id><gtr:title>Response to letter regarding article, &amp;quot;Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acea86a51f490daeab90416072f26605"><gtr:id>acea86a51f490daeab90416072f26605</gtr:id><gtr:otherNames>Yu E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5454ab504a8640.62041925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DCFD060-1BE9-41AD-99CF-ABF8DD8C67B1</gtr:id><gtr:title>Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85f23686da9e1d85aec9daafee5fc2d2"><gtr:id>85f23686da9e1d85aec9daafee5fc2d2</gtr:id><gtr:otherNames>L?pez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>585d4ef9e58507.93427819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3122B12F-40B6-4EE3-B200-67829E13F5BE</gtr:id><gtr:title>Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fbfd715cfa7a742a5e3d8de973a98c"><gtr:id>89fbfd715cfa7a742a5e3d8de973a98c</gtr:id><gtr:otherNames>Rodriguez-Cuenca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>815C76E12B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F1128C0-8D31-41E0-9874-B906FF471B88</gtr:id><gtr:title>Not all mitochondrial carrier proteins support permeability transition pore formation: no involvement of uncoupling protein 1.</gtr:title><gtr:parentPublicationTitle>Bioscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c02b979bd11edf804a3aa9fa4199f72"><gtr:id>8c02b979bd11edf804a3aa9fa4199f72</gtr:id><gtr:otherNames>Crichton PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0144-8463</gtr:issn><gtr:outcomeId>1DE077880C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40674C26-E092-49D5-AFBA-1C6AAE58B751</gtr:id><gtr:title>Dysregulation of glucose homeostasis in nicotinamide nucleotide transhydrogenase knockout mice is independent of uncoupling protein 2.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91967e35364d6f2fa8458eefc62ced17"><gtr:id>91967e35364d6f2fa8458eefc62ced17</gtr:id><gtr:otherNames>Parker N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>FAB7DD0E8CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24FCFA5E-E94B-4B90-9112-C9EAEFCB7C14</gtr:id><gtr:title>Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f266c5de1e93507f08d86a8b7da2032d"><gtr:id>f266c5de1e93507f08d86a8b7da2032d</gtr:id><gtr:otherNames>Tang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>F9018CE75AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35EE40DB-8401-4DAD-9739-73F6C7DFEA62</gtr:id><gtr:title>Lipidomics: a new window to biomedical frontiers.</gtr:title><gtr:parentPublicationTitle>Trends in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65e206b16f90462410d36588fd564b5b"><gtr:id>65e206b16f90462410d36588fd564b5b</gtr:id><gtr:otherNames>Oresic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0167-7799</gtr:issn><gtr:outcomeId>1C06705C67F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9594B996-2002-4DDD-B742-E02190B29D63</gtr:id><gtr:title>Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a83d91cb92130960ceb8bd8bd2f5d62"><gtr:id>1a83d91cb92130960ceb8bd8bd2f5d62</gtr:id><gtr:otherNames>Schreiber R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cdf4dbb6ed89.00910544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25C3E337-0797-4252-AA85-D6562F42B00D</gtr:id><gtr:title>Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85f23686da9e1d85aec9daafee5fc2d2"><gtr:id>85f23686da9e1d85aec9daafee5fc2d2</gtr:id><gtr:otherNames>L?pez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>D858283B8DA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8714720D-A319-4C4B-BC37-B354A4CD71AA</gtr:id><gtr:title>UCPs--unlikely calcium porters.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c270a2b4bfbdf7ada0c1b7c6d834efc0"><gtr:id>c270a2b4bfbdf7ada0c1b7c6d834efc0</gtr:id><gtr:otherNames>Brookes PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>A3E29757393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82D54DB9-984A-4C3F-BA1F-18440FA3D364</gtr:id><gtr:title>AMPK: a metabolic gauge regulating whole-body energy homeostasis.</gtr:title><gtr:parentPublicationTitle>Trends in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/422d30eccdd562eed9cf5fc7563ec606"><gtr:id>422d30eccdd562eed9cf5fc7563ec606</gtr:id><gtr:otherNames>Lage R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-4914</gtr:issn><gtr:outcomeId>97CEBE6F9C4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>957B9B52-8D0D-4042-9586-7AE55F349AD3</gtr:id><gtr:title>Assessment of plasma acylcarnitines before and after weight loss in obese subjects.</gtr:title><gtr:parentPublicationTitle>Archives of biochemistry and biophysics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df8f26177b5e893b616c20790e446002"><gtr:id>df8f26177b5e893b616c20790e446002</gtr:id><gtr:otherNames>Schooneman MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9861</gtr:issn><gtr:outcomeId>58b96da83cf545.54452190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB4DCA30-440D-4B03-ACA2-E8B3491177C6</gtr:id><gtr:title>Stearoyl-CoA Desaturase 1 Is a Key Determinant of Membrane Lipid Composition in 3T3-L1 Adipocytes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fbfd715cfa7a742a5e3d8de973a98c"><gtr:id>89fbfd715cfa7a742a5e3d8de973a98c</gtr:id><gtr:otherNames>Rodriguez-Cuenca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b96da9911239.93255173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD02B5FF-7267-4153-AFC3-D52DCB1D8676</gtr:id><gtr:title>Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2f6fa35b5d82a323e0c15bcb6bdef6d"><gtr:id>a2f6fa35b5d82a323e0c15bcb6bdef6d</gtr:id><gtr:otherNames>Pellegrinelli V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>58b96da86913f3.12801721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4AB31DE-B134-40E2-9F83-A65BF6B476DD</gtr:id><gtr:title>It's not how fat you are, it's what you do with it that counts.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>FC3CB5510B0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B0982EB-D478-4CB5-9048-1BD5B5A57BBD</gtr:id><gtr:title>Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8136c7b8ec31ce2d668e96fa6bbfe41"><gtr:id>d8136c7b8ec31ce2d668e96fa6bbfe41</gtr:id><gtr:otherNames>Medina-Gomez G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>E78BA49D30F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61E1F6ED-6E8B-4BD7-9004-C66ED839B62D</gtr:id><gtr:title>Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5000068f7874c1e0a307208df0d9dd34"><gtr:id>5000068f7874c1e0a307208df0d9dd34</gtr:id><gtr:otherNames>Lagathu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>7981D633AB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0E9DF81-DE30-45EA-AEF6-03B27A27919B</gtr:id><gtr:title>Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD.</gtr:title><gtr:parentPublicationTitle>Seminars in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fe0043d25a0888851cac9f3a9f58eb4"><gtr:id>7fe0043d25a0888851cac9f3a9f58eb4</gtr:id><gtr:otherNames>Vacca M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0272-8087</gtr:issn><gtr:outcomeId>56cdf4dccdbbc4.86135603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8849645E-B62B-4D1C-B8CF-1E97E757DD12</gtr:id><gtr:title>Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/868944d48eed9c849dce745b475cdcc6"><gtr:id>868944d48eed9c849dce745b475cdcc6</gtr:id><gtr:otherNames>Lee EY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56cdf4db8424c3.33312852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2D56012-C2A7-4EA2-BB25-FEDF00F5BBBA</gtr:id><gtr:title>Human Adipocytes Induce Inflammation and Atrophy in Muscle Cells During Obesity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2f6fa35b5d82a323e0c15bcb6bdef6d"><gtr:id>a2f6fa35b5d82a323e0c15bcb6bdef6d</gtr:id><gtr:otherNames>Pellegrinelli V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>56cdf4dc516829.71235476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B5CFD5E-113B-489A-914F-C0224064F220</gtr:id><gtr:title>Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21cb25ff8772b4c914687a805b1d4c64"><gtr:id>21cb25ff8772b4c914687a805b1d4c64</gtr:id><gtr:otherNames>Yew Tan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56cdf4db555988.55544117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF189934-08EE-4794-AD7F-5255F4028128</gtr:id><gtr:title>Adipogenesis and WNT signalling.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43e6dd01a0bbb2326585f704f43f97ac"><gtr:id>43e6dd01a0bbb2326585f704f43f97ac</gtr:id><gtr:otherNames>Christodoulides C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>00CED9E2F36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA253852-66B0-47E3-840A-D22B0D2990FB</gtr:id><gtr:title>IGF-binding protein-2 protects against the development of obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d1c8bc33203062872670d74466f43e1"><gtr:id>6d1c8bc33203062872670d74466f43e1</gtr:id><gtr:otherNames>Wheatcroft SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>83945DED9B8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>668D6AEA-6116-4C92-B7AC-CDB120A75207</gtr:id><gtr:title>Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation.</gtr:title><gtr:parentPublicationTitle>Journal of lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b3597d942b94ab4a3cb6c982a639198"><gtr:id>4b3597d942b94ab4a3cb6c982a639198</gtr:id><gtr:otherNames>Sethi JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2275</gtr:issn><gtr:outcomeId>248CAA2A156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC93D427-2232-4DC2-9B0B-21DA53ECB312</gtr:id><gtr:title>PPARs and adipocyte function.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43e6dd01a0bbb2326585f704f43f97ac"><gtr:id>43e6dd01a0bbb2326585f704f43f97ac</gtr:id><gtr:otherNames>Christodoulides C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>FD74BCC1685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54D037C7-4170-4A5A-B25C-6CD1525E8948</gtr:id><gtr:title>Methods for performing lipidomics in white adipose tissue.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>5454ab50945a63.26442030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79F06A85-C872-4870-8989-1147B27DE168</gtr:id><gtr:title>Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6013e7c1934b6d55026ed02e21ab0c8"><gtr:id>d6013e7c1934b6d55026ed02e21ab0c8</gtr:id><gtr:otherNames>Patel MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cdf4dd6a30c4.18057144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8872E6C-68E8-4A49-9BDB-00C8FC2B947E</gtr:id><gtr:title>Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0fe1561e92f157420919eb81c6a910"><gtr:id>5b0fe1561e92f157420919eb81c6a910</gtr:id><gtr:otherNames>Tan CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>3F498EF7510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5F9F740-CB0C-4585-84A8-D2966FD044FA</gtr:id><gtr:title>Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f33fe815c0b14c9ca7b1106a0ea0cdef"><gtr:id>f33fe815c0b14c9ca7b1106a0ea0cdef</gtr:id><gtr:otherNames>Morton NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>58b96da892be23.81672728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5B123FB-B33D-452E-9CB7-A5B0781DAF88</gtr:id><gtr:title>Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85f23686da9e1d85aec9daafee5fc2d2"><gtr:id>85f23686da9e1d85aec9daafee5fc2d2</gtr:id><gtr:otherNames>L?pez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>BBF10AEDEC1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>520A95FF-2B8A-4537-9C13-8AA9B2670023</gtr:id><gtr:title>The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43e6dd01a0bbb2326585f704f43f97ac"><gtr:id>43e6dd01a0bbb2326585f704f43f97ac</gtr:id><gtr:otherNames>Christodoulides C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>CD3B4F0E77E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E570A50-17E2-4339-98C6-B0E4889F285E</gtr:id><gtr:title>Brain lipogenesis and regulation of energy metabolism.</gtr:title><gtr:parentPublicationTitle>Current opinion in clinical nutrition and metabolic care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85f23686da9e1d85aec9daafee5fc2d2"><gtr:id>85f23686da9e1d85aec9daafee5fc2d2</gtr:id><gtr:otherNames>L?pez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1363-1950</gtr:issn><gtr:outcomeId>5224628C8AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>610238C6-806F-4F59-8282-3C1DDD9431D2</gtr:id><gtr:title>Regulation of mitochondrial morphology and function by stearoylation of TFR1.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ebcc3b3a811bc866b680f632d96c20"><gtr:id>79ebcc3b3a811bc866b680f632d96c20</gtr:id><gtr:otherNames>Senyilmaz D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56cdf4dc9af208.95616123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F265109F-1F50-4BAD-A8F5-61ADC31FDF93</gtr:id><gtr:title>Ribosomal S6K1 in POMC and AgRP Neurons Regulates Glucose Homeostasis but Not Feeding Behavior in Mice.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84d3a573c1453e15a13c9f49a575fa11"><gtr:id>84d3a573c1453e15a13c9f49a575fa11</gtr:id><gtr:otherNames>Smith MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cdf4dd3a7ff7.29056381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BB71ED2-6FDB-45AB-9A4D-D337499BE006</gtr:id><gtr:title>Uncoupling protein-1 (UCP1) contributes to the basal proton conductance of brown adipose tissue mitochondria.</gtr:title><gtr:parentPublicationTitle>Journal of bioenergetics and biomembranes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91967e35364d6f2fa8458eefc62ced17"><gtr:id>91967e35364d6f2fa8458eefc62ced17</gtr:id><gtr:otherNames>Parker N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0145-479X</gtr:issn><gtr:outcomeId>2C6708EF813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5A6544B-F3F7-4947-82D0-AEE2EE88336D</gtr:id><gtr:title>[Adipose tissue as a therapeutic target in obesity].</gtr:title><gtr:parentPublicationTitle>Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/046a9cb9b6d6b3063a8df72949547eca"><gtr:id>046a9cb9b6d6b3063a8df72949547eca</gtr:id><gtr:otherNames>Medina-G?mez G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1575-0922</gtr:issn><gtr:outcomeId>DA3247B2B15</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12C169FA-11C4-4FA4-A431-1C514B54F057</gtr:id><gtr:title>Mitochondria are required for pro-ageing features of the senescent phenotype.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3e216bbe4afc1611d3f8d443f0cc45"><gtr:id>bc3e216bbe4afc1611d3f8d443f0cc45</gtr:id><gtr:otherNames>Correia-Melo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>56cdf4da8416e5.67648654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>918FAF0F-9CC5-45CE-BD01-9A84AD34EC24</gtr:id><gtr:title>CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0728d7aff5ab517e1c918e7c7a54d04a"><gtr:id>0728d7aff5ab517e1c918e7c7a54d04a</gtr:id><gtr:otherNames>Chavey C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>02623204514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07EEAB9E-9E24-4EFE-97CC-F784A3AFE224</gtr:id><gtr:title>Extracellular Vesicles: Novel Mediators of Cell Communication In Metabolic Disease.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120893d6db842ae2fac96265727b0fb4"><gtr:id>120893d6db842ae2fac96265727b0fb4</gtr:id><gtr:otherNames>Huang-Doran I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>58b96da8d8c014.87269105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>748D092B-A934-4BDE-BAC2-59FD0BD1DE34</gtr:id><gtr:title>Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>56cdf4dd0461b3.29863385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBF7432A-BDBD-41CB-93A4-998DA655D0FA</gtr:id><gtr:title>Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c76c446e6a2d372e762aff1c0ce3437"><gtr:id>9c76c446e6a2d372e762aff1c0ce3437</gtr:id><gtr:otherNames>Moreno-Navarrete JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>56cdf4dc26d7c3.92312199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AA28DB6-E8B6-4391-BF63-BC3A2CACF98D</gtr:id><gtr:title>Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge.</gtr:title><gtr:parentPublicationTitle>Nutrition (Burbank, Los Angeles County, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/947476ab11b5f540ac4ddcdb10391e29"><gtr:id>947476ab11b5f540ac4ddcdb10391e29</gtr:id><gtr:otherNames>Paniagua JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0899-9007</gtr:issn><gtr:outcomeId>5454ab50eae3f4.43417567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08B13868-58E6-4DA2-9996-74D4BC31FD32</gtr:id><gtr:title>PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8136c7b8ec31ce2d668e96fa6bbfe41"><gtr:id>d8136c7b8ec31ce2d668e96fa6bbfe41</gtr:id><gtr:otherNames>Medina-Gomez G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>6544AFD60CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>476309A9-D4E0-4BE5-852C-792BDC78AD09</gtr:id><gtr:title>Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesity.</gtr:title><gtr:parentPublicationTitle>Nutrition journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df813db47b72f32fdc1491b2b96ec495"><gtr:id>df813db47b72f32fdc1491b2b96ec495</gtr:id><gtr:otherNames>Parvaresh Rizi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2891</gtr:issn><gtr:outcomeId>58b96da9057fe4.80858977</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400192</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>